Emerging role of F-box proteins in the regulation of epithelial-mesenchymal transition and stem cells in human cancers.


Journal

Stem cell research & therapy
ISSN: 1757-6512
Titre abrégé: Stem Cell Res Ther
Pays: England
ID NLM: 101527581

Informations de publication

Date de publication:
18 04 2019
Historique:
entrez: 20 4 2019
pubmed: 20 4 2019
medline: 26 6 2020
Statut: epublish

Résumé

Emerging evidence shows that epithelial-mesenchymal transition (EMT) plays a crucial role in tumor invasion, metastasis, cancer stem cells, and drug resistance. Data obtained thus far have revealed that F-box proteins are critically involved in the regulation of the EMT process and stem cell differentiation in human cancers. In this review, we will briefly describe the role of EMT and stem cells in cell metastasis and drug resistance. We will also highlight how numerous F-box proteins govern the EMT process and stem cell survival by controlling their downstream targets. Additionally, we will discuss whether F-box proteins involved in drug resistance are associated with EMT and cancer stem cells. Targeting these F-box proteins might be a potential therapeutic strategy to reverse EMT and inhibit cancer stem cells and thus overcome drug resistance in human cancers.

Identifiants

pubmed: 30999935
doi: 10.1186/s13287-019-1222-0
pii: 10.1186/s13287-019-1222-0
pmc: PMC6472071
doi:

Substances chimiques

F-Box Proteins 0
Neoplasm Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

124

Références

Oncogene. 2005 Nov 14;24(50):7443-54
pubmed: 16288291
Cancer Cell. 2014 Sep 8;26(3):358-373
pubmed: 25203322
Biochem Biophys Res Commun. 2007 Jul 20;359(1):34-9
pubmed: 17532294
Proc Natl Acad Sci U S A. 2001 Dec 4;98(25):14440-5
pubmed: 11717410
Oncotarget. 2015 Aug 21;6(24):19968-75
pubmed: 26343523
J Clin Invest. 2004 Oct;114(8):1058-71
pubmed: 15489953
Genes Dev. 2008 Apr 15;22(8):986-91
pubmed: 18367647
Oncogene. 2009 Sep 3;28(35):3157-66
pubmed: 19581926
Nat Rev Drug Discov. 2011 Jan;10(1):29-46
pubmed: 21151032
Br J Cancer. 2014 Apr 15;110(8):1958-67
pubmed: 24642627
Nat Rev Cancer. 2007 Jun;7(6):415-28
pubmed: 17508028
PLoS One. 2017 May 4;12(5):e0176879
pubmed: 28472177
J Biol Chem. 2003 Jul 11;278(28):25752-7
pubmed: 12730199
EMBO Mol Med. 2014 Jan;6(1):99-119
pubmed: 24357640
Cancer Lett. 2015 Jun 28;362(1):70-82
pubmed: 25827072
Cell Cycle. 2017;16(24):2374-2385
pubmed: 28949784
PLoS One. 2008 Jan 23;3(1):e1487
pubmed: 18213395
Blood. 2011 Nov 17;118(20):5429-38
pubmed: 21931116
Neural Dev. 2007 Aug 15;2:16
pubmed: 17697379
J Cancer Res Clin Oncol. 2018 Aug;144(8):1509-1521
pubmed: 29728763
J Biol Chem. 2009 Feb 27;284(9):5488-96
pubmed: 19117950
Nucleic Acids Res. 2014 Jan;42(2):1079-94
pubmed: 24157836
J Biol Chem. 2009 Feb 13;284(7):4413-21
pubmed: 19073596
Cancer Cell. 2017 Mar 13;31(3):411-423
pubmed: 28292439
Nat Rev Cancer. 2006 May;6(5):369-81
pubmed: 16633365
J Biol Chem. 2010 Feb 5;285(6):3840-9
pubmed: 19996097
J Exp Med. 2007 Aug 6;204(8):1813-24
pubmed: 17646409
Oncol Lett. 2018 Mar;15(3):3694-3702
pubmed: 29456733
Cancer Lett. 2017 Aug 10;401:53-62
pubmed: 28456659
Blood. 2008 May 1;111(9):4690-9
pubmed: 18305219
Cancer Cell. 2009 May 5;15(5):416-28
pubmed: 19411070
Mol Cancer Res. 2018 Feb;16(2):286-295
pubmed: 29117943
Mol Cancer Res. 2012 Oct;10(10):1319-31
pubmed: 22912335
Circ Res. 2011 Jul 8;109(2):161-71
pubmed: 21617130
Oncotarget. 2015 Jan 20;6(2):979-94
pubmed: 25460509
Mol Cancer. 2017 Jul 17;16(1):123
pubmed: 28716020
Hepatobiliary Pancreat Dis Int. 2014 Apr;13(2):184-91
pubmed: 24686546
Blood. 2011 Jun 16;117(24):6509-19
pubmed: 21502543
Medicine (Baltimore). 2016 Feb;95(7):e2496
pubmed: 26886596
PLoS One. 2013 Dec 13;8(12):e83244
pubmed: 24349473
Nat Rev Cancer. 2014 Apr;14(4):233-47
pubmed: 24658274
Cancer Metastasis Rev. 2012 Jun;31(1-2):75-87
pubmed: 22124735
Biochem Biophys Res Commun. 2001 Apr 13;282(4):853-60
pubmed: 11352628
Nat Rev Mol Cell Biol. 2006 Feb;7(2):131-42
pubmed: 16493418
Nat Rev Mol Cell Biol. 2008 Sep;9(9):679-90
pubmed: 18698327
Annu Rev Biochem. 2012;81:231-59
pubmed: 22404628
Biochim Biophys Acta. 2015 Aug;1856(1):55-61
pubmed: 26050961
Neoplasia. 2018 Aug;20(8):813-825
pubmed: 30015157
Cancer Res. 2018 Sep 15;78(18):5274-5286
pubmed: 29945959
Int J Oncol. 2018 Jun;52(6):1841-1852
pubmed: 29620168
Oncogene. 2017 Jul 27;36(30):4299-4310
pubmed: 28346424
Biomed Pharmacother. 2018 Feb;98:416-423
pubmed: 29278851
Oncotarget. 2014 Jul 30;5(14):5591-601
pubmed: 25015320
J Biol Chem. 2003 Oct 31;278(44):43877-84
pubmed: 12939278
Cancer Res. 2016 Mar 15;76(6):1451-62
pubmed: 26759241
Oncol Rep. 2017 Aug;38(2):1190-1198
pubmed: 28656290
Genes Chromosomes Cancer. 2002 May;34(1):9-16
pubmed: 11921277
Cancer Res. 2005 Dec 15;65(24):11304-13
pubmed: 16357137
Cancer Res. 2018 Mar 1;78(5):1334-1346
pubmed: 29282223
Nat Med. 2011 Mar;17(3):313-9
pubmed: 21386835
Acta Biochim Biophys Sin (Shanghai). 2018 Jun 1;50(6):597-604
pubmed: 29701752
Trends Neurosci. 2009 Nov;32(11):559-65
pubmed: 19748686
Genes Dev. 2007 May 1;21(9):1050-63
pubmed: 17437993
Cell. 2009 Jun 26;137(7):1358, 1358.e1
pubmed: 19563764
J Biol Chem. 2010 Feb 5;285(6):3794-805
pubmed: 19955572
Nature. 1998 Dec 10;396(6711):590-4
pubmed: 9859996
J Cell Biol. 2011 Jul 11;194(1):17-25
pubmed: 21727196
Cancer Lett. 2018 Apr 10;419:75-83
pubmed: 29355657
Am J Transl Res. 2016 Jun 15;8(6):2512-24
pubmed: 27398136
J Exp Med. 2017 Jan;214(1):245-267
pubmed: 27923907
Oncogene. 2004 Mar 15;23(11):2028-36
pubmed: 15021890
Annu Rev Biochem. 2012;81:167-76
pubmed: 22663079
Biochem Biophys Res Commun. 2018 Jan 15;495(3):2158-2164
pubmed: 29269301
Nat Rev Mol Cell Biol. 2014 Mar;15(3):178-96
pubmed: 24556840
Nature. 2004 Jul 15;430(6997):345-50
pubmed: 15208641
Nat Rev Drug Discov. 2006 Jul;5(7):596-613
pubmed: 16816840
Oncotarget. 2015 Dec 8;6(39):41766-82
pubmed: 26497204
Proc Natl Acad Sci U S A. 2012 Apr 17;109(16):5934-41
pubmed: 22421440
Cell Physiol Biochem. 2015;35(5):1764-72
pubmed: 25832584
Oncotarget. 2015 Mar 20;6(8):6310-25
pubmed: 25749036
Nat Cell Biol. 1999 Aug;1(4):193-9
pubmed: 10559916
Oncol Rep. 2005 Aug;14(2):531-5
pubmed: 16012741
Cancer Cell. 2014 Oct 13;26(4):455-64
pubmed: 25314076
Annu Rev Biochem. 2009;78:399-434
pubmed: 19489725
Cell. 2013 Jun 20;153(7):1552-66
pubmed: 23791182
PLoS One. 2012;7(4):e36249
pubmed: 22558406
Asian Pac J Cancer Prev. 2013;14(11):6321-6
pubmed: 24377525
Cell. 1996 Jul 26;86(2):263-74
pubmed: 8706131
J Invest Dermatol. 2014 Jan;134(1):159-167
pubmed: 23792459
Nat Rev Cancer. 2011 Aug 24;11(9):629-43
pubmed: 21863050
Oncotarget. 2015 Sep 8;6(26):22767-75
pubmed: 26087183
Cell Cycle. 2006 Jul;5(14):1569-73
pubmed: 16861914
Nat Rev Cancer. 2008 Feb;8(2):83-93
pubmed: 18094723
Nature. 2012 Jan 5;481(7379):90-3
pubmed: 22113614
Cell Signal. 2018 Jun;46:15-22
pubmed: 29474981
Nat Rev Cancer. 2013 Feb;13(2):97-110
pubmed: 23344542
Proc Natl Acad Sci U S A. 1998 Sep 15;95(19):11324-9
pubmed: 9736735
Nat Commun. 2017 Nov 15;8(1):1523
pubmed: 29142217
Mol Cell Biol. 2009 Jul;29(13):3529-43
pubmed: 19398581
Cell. 2009 Nov 25;139(5):871-90
pubmed: 19945376
APMIS. 2007 Feb;115(2):127-33
pubmed: 17295679
Dis Markers. 2017;2017:8276939
pubmed: 29097832
Cell. 2013 Aug 1;154(3):556-68
pubmed: 23911321
Oncol Rep. 2017 Feb;37(2):1052-1058
pubmed: 28000899
Nat Rev Cancer. 2008 Nov;8(11):835-50
pubmed: 18948996
Biochem Biophys Res Commun. 2014 Mar 14;445(3):566-71
pubmed: 24561244
Mol Cell Biol. 2011 Sep;31(18):3687-99
pubmed: 21768309
Blood. 2015 May 28;125(22):3437-46
pubmed: 25872778
Biol Chem. 2010 Feb-Mar;391(2-3):163-9
pubmed: 20030582
Discov Med. 2013 Jan;15(80):7-15
pubmed: 23375009
Nature. 2001 Nov 1;414(6859):105-11
pubmed: 11689955
Microrna. 2014;3(2):108-17
pubmed: 25323025
Bioorg Med Chem. 2013 Jun 15;21(12):3400-10
pubmed: 23485445
Science. 2001 Nov 23;294(5547):1704-8
pubmed: 11679633
Int J Dev Biol. 2004;48(5-6):365-75
pubmed: 15349812
J Biol Chem. 2005 Jan 28;280(4):2847-56
pubmed: 15531760
Cell. 2004 Jun 25;117(7):927-39
pubmed: 15210113
Nat Cell Biol. 2004 Oct;6(10):931-40
pubmed: 15448698
Cell Cycle. 2005 Jun;4(6):772-6
pubmed: 15917668
Nat Rev Mol Cell Biol. 2013 Jun;14(6):369-81
pubmed: 23657496
Cell Death Differ. 2010 Jan;17(1):4-13
pubmed: 19557013
Curr Biol. 1999 Feb 25;9(4):207-10
pubmed: 10074433
Cancer Sci. 2009 Aug;100(8):1374-81
pubmed: 19459846
Cancer Biol Ther. 2006 Sep;5(9):1059-64
pubmed: 16940750
Biochem Biophys Res Commun. 2013 May 3;434(2):352-6
pubmed: 23558291
Cancer Res. 2014 Jul 15;74(14):3659-72
pubmed: 24845104
Curr Opin Oncol. 2013 Jan;25(1):76-84
pubmed: 23197193
Nat Rev Cancer. 2008 Jun;8(6):438-49
pubmed: 18500245
J Exp Clin Cancer Res. 2017 Apr 11;36(1):48
pubmed: 28399926
J Biol Chem. 2014 Jun 27;289(26):18514-25
pubmed: 24828503
RNA Biol. 2015;12(3):276-89
pubmed: 25826661
Nat Rev Mol Cell Biol. 2005 Jan;6(1):9-20
pubmed: 15688063
Nat Commun. 2016 Feb 12;7:10574
pubmed: 26868148
Oncogenesis. 2016 Aug 15;5(8):e254
pubmed: 27526108
Nature. 2009 Jun 4;459(7247):722-5
pubmed: 19412162
Nat Struct Mol Biol. 2014 Apr;21(4):325-35
pubmed: 24699081
Semin Cancer Biol. 2016 Feb;36:71-9
pubmed: 26506454
Oncogene. 2016 May 5;35(18):2287-98
pubmed: 26257063
Curr Biol. 1999 Jun 17;9(12):661-4
pubmed: 10375532
Int J Oncol. 2001 May;18(5):959-64
pubmed: 11295041
Cancer. 1994 Nov 1;74(9):2397-8
pubmed: 7922991
Cancer Lett. 2016 Jan 1;370(1):39-55
pubmed: 26458995
Curr Opin Cell Biol. 2013 Apr;25(2):200-7
pubmed: 23434068
J Biol Chem. 1998 Dec 25;273(52):35222-7
pubmed: 9857061
Science. 2007 Nov 16;318(5853):1108-13
pubmed: 17932254
Annu Rev Biochem. 1998;67:425-79
pubmed: 9759494
JCI Insight. 2016 Nov 03;1(18):e83654
pubmed: 27812537
J Cell Sci. 2015 Mar 15;128(6):1123-38
pubmed: 25632159
Sci Signal. 2014 Sep 23;7(344):re8
pubmed: 25249658

Auteurs

Yizuo Song (Y)

Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Wenzhou Medical University, No. 109 Xueyuan Xi Road, Wenzhou, 325027, Zhejiang, China.

Min Lin (M)

Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Wenzhou Medical University, No. 109 Xueyuan Xi Road, Wenzhou, 325027, Zhejiang, China.

Yi Liu (Y)

Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Wenzhou Medical University, No. 109 Xueyuan Xi Road, Wenzhou, 325027, Zhejiang, China.

Zhi-Wei Wang (ZW)

Center of Scientific Research, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325027, Zhejiang, China. zwang6@bidmc.harvard.edu.
Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA. zwang6@bidmc.harvard.edu.

Xueqiong Zhu (X)

Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Wenzhou Medical University, No. 109 Xueyuan Xi Road, Wenzhou, 325027, Zhejiang, China. zjwzzxq@163.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH